Abstract
Recently, stem cell therapy has been investigated as a strategy to prevent or reverse damage to heart tissue. Although the results of cell transplantation in animal models and patients with myocardial ischemia are promising, the selection of the appropriate cell type remains an issue that requires consideration. In this study, we aimed to evaluate the effect of cardiac progenitor cell transplantation in a mouse model of myocardial ischemia. The cardiac progenitor cells used for transplantation were differentiated from umbilical cord blood mesenchymal stem cells. Animal models injected with phosphate-buffered saline (PBS) and healthy mice were used as controls. Cell grafting was assessed by changes in blood pressure and histological evaluation. After 14 days of transplantation, the results demonstrated that the blood pressure of transplanted mice was stable, similar to healthy mice, whereas it fluctuated in PBS injected mice. Histological analysis showed that heart tissue had regenerated in transplanted mice, but remained damaged in PBS-injected mice. Furthermore, trichrome staining revealed that the transplanted mice did not generate significant amount of scar tissue compared with PBS-injected control mice. In addition, the cardiac progenitor cells managed to survive and integrate with local cells in cell-injected heart tissue 14 days after transplantation. Most importantly, the transplanted cells did not exhibit tumorigenesis. In conclusion, cardiac progenitor cell transplantation produced a positive effect in a mouse model of myocardial ischemia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Quyyumi AA, Waller EK, Murrow J et al (2011) CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J 161:98–105
Karantalis V, Balkan W, Schulman IH et al (2012) Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol 303:H256–H270
Henning RJ, Shariff M, Eadula U et al (2008) Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute myocardial infarction. Stem Cells Dev 17:1207–1219
Pham TL, Nguyen TT, Van Bui A et al (2014) Fetal heart extract facilitates the differentiation of human umbilical cord blood-derived mesenchymal stem cells into heart muscle precursor cells. Cytotechnology. doi:10.1007/s10616-014-9812-2
Nussbaum J, Minami E, Laflamme MA et al (2007) Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J Off Publ Fed Am Soc Exp Biol 21:1345–1357
Huber I, Itzhaki I, Caspi O et al (2007) Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J Off Publ Fed Am Soc Exp Biol 21:2551–2563
Mazo M, Araña M, Pelacho B et al (2012) Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap. Stem Cells Int 11
Acknowledgements
This work was supported by Vietnam National University Ho Chi Minh City, Vietnam under the grant B2011-18-07TD.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Pham, T.L.B. et al. (2018). Evaluation of Treatment Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cell-Differentiated Cardiac Progenitor Cells in a Myocardial Injury Mouse Model. In: Vo Van, T., Nguyen Le, T., Nguyen Duc, T. (eds) 6th International Conference on the Development of Biomedical Engineering in Vietnam (BME6) . BME 2017. IFMBE Proceedings, vol 63. Springer, Singapore. https://doi.org/10.1007/978-981-10-4361-1_144
Download citation
DOI: https://doi.org/10.1007/978-981-10-4361-1_144
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4360-4
Online ISBN: 978-981-10-4361-1
eBook Packages: EngineeringEngineering (R0)